title: Parenchymal expression of CD40 exacerbates adenovirus-induced hepatitis in mice.
abstract: The healthy adult human liver expresses low levels of major histocompatibility complex class II (MHC II) and undetectable levels of immune costimulatory molecules. However, high levels of MHC II, CD40, and B7 family molecules are expressed in the activated Kupffer cells and hepatocytes of patients with viral hepatitis. The precise role of these molecules in viral clearance and immune-mediated liver injury is not well understood. We hypothesized that parenchymal CD40 expression enhances T cell recruitment and effector functions, which may facilitate viral clearance and alleviate liver injury. To test this hypothesis, we generated novel liver-specific, conditional CD40 transgenic mice, and we challenged them intravenously with a recombinant replication-deficient adenovirus carrying Cre recombinase (AdCre). Wild-type mice infected with AdCre developed a relatively mild course of viral hepatitis and recovered spontaneously. CD40 expression in the livers of transgenic animals, however, resulted in CD80 and CD86 expression. The dysregulation of population dynamics and effector functions of intrahepatic lymphocytes (IHLs) resulted in severe lymphocytic infiltration, apoptosis, necroinflammation, and serum alanine aminotransferase elevations in a dose-dependent fashion. To our surprise, an early expansion and subsequent contraction of IHLs (especially CD8(+) and natural killer cells), accompanied by increased granzyme B and interferon-γ production, did not lead to faster viral clearance in CD40 transgenic mice.
  
  
  CONCLUSIONS
  Our results demonstrate that hepatic CD40 expression does not accelerate adenoviral clearance but rather exacerbates liver injury. This study unveils a previously unknown deleterious effect of hepatic CD40 on adenovirus-induced liver inflammation.
authors.affiliation: Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
authors.forename: Jiabin
authors.initials: J
authors.lastname: Yan
authors.forename: Zuliang
authors.initials: Z
authors.lastname: Jie
authors.forename: Lifei
authors.initials: L
authors.lastname: Hou
authors.forename: Joao L
authors.initials: JL
authors.lastname: Wanderley
authors.forename: Lynn
authors.initials: L
authors.lastname: Soong
authors.forename: Shalini
authors.initials: S
authors.lastname: Gupta
authors.forename: Suimin
authors.initials: S
authors.lastname: Qiu
authors.forename: Tehsheng
authors.initials: T
authors.lastname: Chan
authors.forename: Jiaren
authors.initials: J
authors.lastname: Sun
mesh_terms: D000257:Adenoviridae Infections / Q000276:immunology / Q000378:metabolism*; D000818:Animals; D019013:CD40 Antigens / Q000096:biosynthesis*; D006524:Hepatitis, Viral, Animal / Q000276:immunology / Q000378:metabolism*; D008099:Liver / Q000276:immunology / Q000378:metabolism*; D008214:Lymphocytes / Q000276:immunology; D051379:Mice; D008822:Mice, Transgenic; D012720:Severity of Illness Index
chemical_list: D019013:CD40 Antigens